Hamilton Lane Advisors’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-19,255
Closed -$44.5K 54
2023
Q2
$44.5K Sell
19,255
-35,000
-65% -$98.8K 0.02% 51
2023
Q1
$138K Hold
54,255
0.05% 55
2022
Q4
$136K Buy
+54,255
New +$151K 0.05% 60

Other funds holding SLGC

Hamilton Lane Advisors's SLGC Position: Q3 2023 in Review

Hamilton Lane Advisors sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q3 2023, closing a stake of 19,255 shares — an estimated $44.5K sold.

Hamilton Lane Advisors first reported a position in SLGC in Q4 2022 and held it in 3 quarters. The position peaked at $138K in Q1 2023. 118 funds tracked by Wall St. Rank hold SLGC as of Q3 2023.

  • Hamilton Lane Advisors reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Hamilton Lane Advisors sold 19,255 SomaLogic, Inc. Class A Common Stock shares in Q3 2023, an estimated $44.5K.
  • Hamilton Lane Advisors first reported a position in SomaLogic, Inc. Class A Common Stock in Q4 2022 and held it in 3 quarters.
  • Hamilton Lane Advisors's SomaLogic, Inc. Class A Common Stock position peaked at $138K in Q1 2023.
  • 118 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q3 2023.

Based on Hamilton Lane Advisors's 13F filing for Q3 2023, filed 7 Nov 2023.